Profiel
Guy Debruyne is currently a Director at Le Bocholtz SA, Mithra Pharmaceuticals CDMO SA, Blue Star Invest SA, and a Director at CG Cube SA. He was previously a Non-Executive Director at Mithra Pharmaceuticals SA.
Actieve functies van Guy Debruyne
| Bedrijven | Functie | Begin |
|---|---|---|
| Blue Star Invest SA | Chief Executive Officer | - |
| CG Cube SA | Director/Board Member | - |
| Le Bocholtz SA | Director/Board Member | - |
Mithra Pharmaceuticals CDMO SA
 Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The private company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Director/Board Member | - |
Eerdere bekende functies van Guy Debruyne
| Bedrijven | Functie | Einde |
|---|---|---|
| MITHRA PHARMACEUTICALS S.A. | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MITHRA PHARMACEUTICALS S.A. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Le Bocholtz SA | |
Mithra Pharmaceuticals CDMO SA
Mithra Pharmaceuticals CDMO SA Pharmaceuticals: MajorHealth Technology Part of Mithra Pharmaceuticals SA, Mithra Pharmaceuticals CDMO SA is a Belgian biotech company that focuses on transforming women's health through innovation. The private company is based in Liege, Belgium and has a global presence in over 100 countries with a staff count of approximately 300. Mithra CDMO is an integrated research, development, and manufacturing platform that takes products from proof of concept to market. The company's current research and development pipeline includes two products based on the novel natural estrogen, estetrol (e4), as well as three complex therapeutics. The company was founded in 2013, and the CEO is François Fornieri. | Health Technology |
| Blue Star Invest SA | |
| CG Cube SA |
